MRNY ETF: What Is It? A Complete Guide to Returns, Expense Ratio, Holdings, and Alternative ETFs
The YieldMax MRNA Option Income Strategy ETF (MRNY) uses an option-selling strategy on a single underlying stock, Moderna, to pursue weekly distributions. For investors looking for high-yield covered call ETFs, it is worth considering as an income-oriented alternative with Moderna-related exposure.
SubscribeWhat Is the YieldMax MRNA Option Income Strategy ETF?
This is an actively managed ETF that uses a synthetic covered call strategy, combining indirect exposure to the share price of Moderna (MRNA) with the collection of option premiums. It does not hold MRNA shares directly. Instead, it replicates a similar payoff structure through option positions.
It suits investors who want regular cash flow from Moderna's price volatility and can accept limited upside potential.
The ETF is actively managed by YieldMax.
How Does the YieldMax MRNA Option Income Strategy ETF Invest?
| Item | Details |
|---|---|
| Tracking Index | None (single stock underlying: Moderna) |
| Management Style | Active (synthetic covered call) |
| Rebalancing Cycle | Rollover at each option expiration |
| Distribution Frequency | Weekly |
| Total Expense Ratio | 1.00% |
Rather than holding Moderna shares directly, the fund gains indirect exposure to the stock's price movement through a synthetic position that combines call option selling and buying. It uses option premiums as the source of its distributions and pays income on a weekly basis. In rising markets, participation in gains is capped within a certain range.
- A representative product group among single stock option income strategies
- A frequent, weekly distribution cycle
YieldMax MRNA Option Income Strategy ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) stand at $237.8M, and the total expense ratio is 1.00% per year.
Its structure is similar to that of NVDY, TSLY, MSTY, and AMDY in the same option income family, differing only in the underlying stock, while the funds show differences in fee levels and asset size.
YieldMax MRNA Option Income Strategy ETF Performance and Trends
1-Year Price Performance
Dividend & Yield
52-Week Price RangeThe ETF rises and falls in line with the volatility of its underlying asset, Moderna's share price. The event-driven volatility typical of the biotech sector tends to be reflected directly in both its return trajectory and the size of its distributions.
Fund flows, both inflows and outflows, have continued alongside growing interest in the single stock option income ETF category as a whole, and demand for high-yield, income-oriented products remains a steady source of attention.
YieldMax MRNA Option Income Strategy ETF Pros and Cons
Frequent weekly distributions are its strength, while concentration in a single stock and limited upside potential stand out as clear drawbacks.
💪 Key Strengths
⚠️ Points of Caution
Alternative ETFs and Related Products to the YieldMax MRNA Option Income Strategy ETF
NVDY, TSLY, MSTY, and AMDY shown in the table are all single stock option income ETFs in the YieldMax family. Each swaps in a different large-cap individual stock as the underlying asset, and they differ in fees, asset size, and underlying volatility. For those who want a product in the same covered call family but diversified across many stocks, diversified income ETFs such as QYLD, a covered call ETF based on the Nasdaq 100, or JEPI, based on the S&P 500, can also serve as points of comparison.
Peer Comparison ETFs| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
 NVDY | YieldMax NVDA Option Income Strategy ETF | $11.08 | -1.1% | $1.3B | 1.09% | 55.29% | -33.8% |
 MSTY | YieldMax MSTR Option Income Strategy ETF | $12.92 | +0.5% | $958.8M | 1.03% | 144.17% | -76.3% |
 FEPI | REX FANG & Innovation Equity Premium Income ETF | $37.85 | -1.9% | $680.7M | 0.65% | 27.19% | -21.8% |
 TSLY | YieldMax TSLA Option Income Strategy ETF | $22.71 | +0.8% | $661.6M | 1.07% | 73.5% | -46.6% |
 AMDY | Yieldmax AMD Option Income Strategy ETF | $37.68 | -7.6% | $442.0M | 1.00% | 85.28% | -23.3% |
Top Holdings| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
 BNO | United States Brent Oil Fund LP | 1.20% | $65.95 | -7.6% | $0.0M | - | - |
 UAMY | United States Antimony Corp | 0.33% | $2.87 | -3.7% | $429.6M | - | - |
 USLM | United States Lime & Minerals Inc | 0.72% | $118.99 | +6.6% | $3.4B | 25.6 | 0.2% |
YieldMax MRNA Option Income Strategy ETF Investor Checkpoints
Here are the points to review before investing in MRNY. High-frequency distributions and option premium collection are attractive, but single stock concentration and the possibility of principal erosion need to be checked carefully in advance.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| 💵 Expense Ratio | Check cumulative costs over a long holding period | Active option strategy fee applies |
| 📉 Single Stock Risk | Degree of exposure to Moderna's individual volatility | Undiversified structure |
| 💰 Distribution Composition | Proportion of income versus return of capital | Needs verification |
| 📈 Limited Upside Participation | Understand the cap on gains during sharp rallies | Synthetic covered call applied |
Moderna's single stock risk and the limited upside participation typical of option strategies are the core risks. If the underlying asset's volatility increases because of biotech sector events, both distributions and net asset value can swing sharply.
This is a specialized product for investors who want Moderna-related income exposure. Those who prefer diversification are advised to compare it with multi-stock covered call ETFs or with holding the stock directly.
SubscribeDisclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of July 2, 2026.
Today's 5 AI picks, all free